Incannex Healthcare’s $93.3 Million Acquisition of APIRx Pharmaceuticals

Thomson Geer advised Incannex Healthcare on the acquisition of APIRx Pharmaceuticals.Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here